{"product_id":"heparin-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Heparin Market: Global  Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eHeparin Market: Global  Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global heparin market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eHeparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina. It is also used in post-surgeries as well as during dialysis and blood transfusion. Heparin is usually injected directly into the muscle or the veins to break up clots and maintain smooth fluidity of the blood. Some common side-effects of using heparin include easy bruising and itchy skin with redness.\u003c\/p\u003e\n\n\u003cp\u003eThe rising prevalence of various medical ailments such as deep vein thrombosis (DVT) and pulmonary embolism (PE) is one of the key factors driving the global market. Also, heparin has been proven to be an extremely effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is contributing significantly to its market growth. Furthermore, biopharmaceutical companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side-effects. Availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation and inflammatory diseases is significantly increasing the adoption of the product. The market is further driven by the various advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Moreover, increasing government funding toward improving healthcare facilities and extensive research and development (R\u0026amp;D) activities to develop heparin with ultra-low molecular weight for utilization in chemotherapy are also creating a positive outlook for the market. \u003c\/p\u003e\n\n\u003cp\u003eIMARC Group’s latest report provides a deep insight into the global heparin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the heparin market in any manner. \u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eIMARC Group provides an analysis of the key trends in each sub-segment of the global heparin market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, source, mode of administration, application, end-user and distribution channel.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eUnfractionated Heparin \u003cbr\u003e\nLow Molecular Weight Heparin (LMWH)\u003cbr\u003e\nUltra-Low Molecular Weight Heparin (ULMWH)\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Source:\u003c\/p\u003e\n\n\u003cp\u003eBovine\u003cbr\u003e\nPorcine\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Mode of Administration:\u003c\/p\u003e\n\n\u003cp\u003eOral\u003cbr\u003e\nParenteral\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eAtrial Fibrillation \u0026amp; Heart Attack\u003cbr\u003e\nStroke\u003cbr\u003e\nDeep Vein Thrombosis (DVT)\u003cbr\u003e\nPulmonary Embolism (PE)\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nClinics\u003cbr\u003e\nHomecare Settings\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Distribution Channel:\u003c\/p\u003e\n\n\u003cp\u003eHospital Pharmacies\u003cbr\u003e\nRetail Pharmacies\u003cbr\u003e\nDrug Stores\u003cbr\u003e\nOnline Stores\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003cbr\u003e\nNorth America\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\nLatin America\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe report has also analyzed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd, Pfizer Inc., LEO Pharma A\/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd. and Dongying Tiandong Pharmaceutical Co., Ltd.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eHow has the global heparin market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global heparin industry?\u003cbr\u003e\nWhat are the key regional markets in the global heparin industry?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the source?\u003cbr\u003e\nWhat is the breakup of the market based on the mode of administration?\u003cbr\u003e\nWhat is the breakup of the market based on the application?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat is the breakup of the market based on the distribution channel?\u003cbr\u003e\nWhat are the various stages in the value chain of the global heparin industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the global heparin industry?\u003cbr\u003e\nWhat is the structure of the global heparin industry and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the global heparin industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 138 Pages \/ MCW16236891","offer_id":47652305666354,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/heparin-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}